viernes, 13 de noviembre de 2026
Rules Governing Human Oversight of AI in Health Care Could Shape Public Trust Joel Luther , Hagere Yilma , and Irving Washington
https://www.kff.org/health-information-trust/rules-governing-human-oversight-of-ai-in-health-care-could-shape-public-trust/
New regulations and guidelines for the use of AI in health care have sought to answer questions about human oversight and accountability. Separately, a new HHS initiative aims to expand research into potential vaccine injuries, but some medical organizations have questioned how the efforts may be perceived.
DC Shooting Suspect Was A Doctor With A Beef Against Condo's HOA, Metro Police Say
DC Shooting Suspect Was A Doctor With A Beef Against Condo's HOA, Metro Police Say
Dr. Matt Lambert died of a self-inflicted gunshot wound during the rampage that left a Logan Circle building manager dead and others wounded, interim Metropolitan Police chief Jeffrey Carroll said. Other state news is about HIV prevention in Texas, a fear of cuts to disability services in Connecticut, and more.
https://kffhealthnews.org/morning-breakout/state-watch-111326/
CMS Extends Medicare Enrollment Moratorium For 6 More Months On Hospice, Home Health Agencies
CMS Extends Medicare Enrollment Moratorium For 6 More Months On Hospice, Home Health Agencies
According to the Centers for Medicare & Medicaid Services, the initial moratorium window has allowed the agency to identify potential cases of fraud and the extension is necessary to continue that effort.
https://kffhealthnews.org/morning-breakout/health-industry-111326/
Allergy Drug Appears To Reduce Alpha-Gal Reactions To Red Meat, Study Shows
Allergy Drug Appears To Reduce Alpha-Gal Reactions To Red Meat, Study Shows
In a limited study of the allergy drug omalizumab, 95% of participants experienced meaningful reductions in the frequency or severity of their allergic reactions, NBC News reported. Plus, an experimental heart drug fails its trial; Biogen's lupus study; and more.
https://kffhealthnews.org/morning-breakout/pharma-and-tech-111326/
HHS Earmarks Nearly $25M For Research Into Psychedelics As Mental Health Treatment
HHS Earmarks Nearly $25M For Research Into Psychedelics As Mental Health Treatment
The Advanced Research Projects Agency for Health and the National Institute of Mental Health will invest millions for research into ibogaine, ketamine, esketamine, and psilocybin as treatments for mental health disorders, including PTSD, as well as for substance use disorders.
https://kffhealthnews.org/morning-breakout/mental-health-111326/
Suscribirse a:
Entradas (Atom)

